Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors

RIPK2 mediates pro-inflammatory signaling from the bacterial sensors NOD1 and NOD2, and is an emerging therapeutic target in autoimmune and inflammatory diseases. We observed that cellular RIPK2 can be potently inhibited by type II inhibitors that displace the kinase activation segment, whereas ATP-...

Descripción completa

Detalles Bibliográficos
Autores principales: Canning, Peter, Ruan, Qui, Schwerd, Tobias, Hrdinka, Matous, Maki, Jenny L., Saleh, Danish, Suebsuwong, Chalada, Ray, Soumya, Brennan, Paul E., Cuny, Gregory D., Uhlig, Holm H., Gyrd-Hansen, Mads, Degterev, Alexei, Bullock, Alex N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579271/
https://www.ncbi.nlm.nih.gov/pubmed/26320862
http://dx.doi.org/10.1016/j.chembiol.2015.07.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579271/
https://www.ncbi.nlm.nih.gov/pubmed/26320862
http://dx.doi.org/10.1016/j.chembiol.2015.07.017

Ejemplares similares